7165 POSTER Sunitinib (SU) Pharmacokinetic (PK)-Pharmacodynamic (PD) Modeling With Respect to Safety and Efficacy Endpoints in Asian Patients With Gastrointestinal Stromal Tumour (GIST) or Renal Cell Carcinoma (RCC) in Pursuit of a Therapeutic Window